5. Microdose Clinical Study for Drug Development-Reference-Cited by-同舟云学术

5. Microdose Clinical Study for Drug Development

Published:2009 Issue:1 Volume:41 Page:27-34
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

MAEDA Kazuya¹,SUGIYAMA Yuichi¹

Affiliation:

1. Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

http://www.jstage.jst.go.jp/article/jscpt/41/1/41_1_27/_pdf

Reference16 articles.

1. 1) Kola I and Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004; 3: 711-5.

2. 2) Frank R and Hargreaves R. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov. 2003; 2: 566-80.

3. 3) Grass GM and Sinko PJ. Physiologically-based pharmacokinetic simulation modelling. Adv Drug Deliv Rev. 2002; 54: 433-51.

4. 4) Chiba M, Ishii Y and Sugiyama Y. Prediction of hepatic clearance in human from in vitro data for successful drug development. Aaps J. 2009; 11: 262-76.

5. 5) Maeda K and Sugiyama Y. In vitro-in vivo scale-up of drug transport activities. You G and Morris ME (Eds). Drug transporters. New Jersey: John Wiley & Sons, Inc., 2007: 557-88.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study;Journal of Separation Science;2011-05-19